[email protected]
CAS 62469-99-2 ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC molecular structure lightbox
CAS RN: 62469-99-2

ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260526 1mg Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS62469-99-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

62469-99-2 / N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide

Standard CAS: 62469-99-2 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
62469-99-2
Multi CAS
Yes
Molecular Formula
C38H65NO29
Molecular Weight
999.900000
Exact Mass
999.364225
InChI
InChI=1S/C38H65NO29/c1-9-18(48)23(53)26(56)35(59-9)66-31-17(39-11(3)45)34(67-32-22(52)15(7-43)61-37(28(32)58)64-29(13(47)5-41)20(50)12(46)4-40)63-16(8-44)30(31)65-38-33(25(55)21(51)14(6-42)62-38)68-36-27(57)24(54)19(49)10(2)60-36/h4,9-10,12-38,41-44,46-58H,5-8H2,1-3H3,(H,39,45)/t9-,10-,12-,13+,14+,15+,16+,17+,18+,19+,20+,21-,22-,23+,24+,25-,26-,27-,28+,29+,30+,31+,32-,33+,34-,35-,36-,37-,38-/m0/s1
InChIKey
SGJFQKVFOUQOTE-URTONSIPSA-N

Computed Properties

Structural Parameters

Heavy atom count
68
Fraction Csp3
0.95
Rotatable bonds
19
H-bond acceptors
29
H-bond donors
18
Molar refractivity
209.12
TPSA
482.38

LogP / Solubility

WLOGP
-12.06
MLOGP
-10.52
XLogP3
-11
Consensus LogP
-11.19
Log S (ESOL)
2.81
Class (ESOL)
Highly soluble
Log S (Ali)
0.95
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
1.57
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-17.38

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Customers Also Viewed

Get In Touch

Contact Us